BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Moon HH, Seo KW, Yoon KY, Shin YM, Choi KH, Lee SH. Prediction of nephrotoxicity induced by cisplatin combination chemotherapy in gastric cancer patients. World J Gastroenterol 2011; 17(30): 3510-3517 [PMID: 21941418 DOI: 10.3748/wjg.v17.i30.3510]
URL: https://www.wjgnet.com/1007-9327/full/v17/i30/3510.htm
Number Citing Articles
1
Zulfan Zazuli, Susanne Vijverberg, Elise Slob, Geoffrey Liu, Bruce Carleton, Joris Veltman, Paul Baas, Rosalinde Masereeuw, Anke-Hilse Maitland-van der Zee. Genetic Variations and Cisplatin Nephrotoxicity: A Systematic ReviewFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01111
2
BEN SPRANGERS, LAURA COSMAI, CAMILLO PORTA. Onco-Nephrology2020; : 127 doi: 10.1016/B978-0-323-54945-5.00025-4
3
Ko Sato, Satoshi Watanabe, Aya Ohtsubo, Satoshi Shoji, Daisuke Ishikawa, Tomohiro Tanaka, Koichiro Nozaki, Rie Kondo, Masaaki Okajima, Satoru Miura, Junta Tanaka, Takuro Sakagami, Toshiyuki Koya, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita. Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factorsBMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2271-8
4
Somayeh Sadat Shariatmaghani, Alireza Saadat, Isa Nazar, Farnoush Davoudi, Shahram Parvin, Hossein Mehrani, Behzad Einollahi. Urinary Neutrophil Gelatinase Associated Lipocalin (NGAL) in Predicting Cisplatin-Induced Acute Kidney InjuryNephro-Urology Monthly 2019; (In Press) doi: 10.5812/numonthly.87523
5
Ekanita Desiani, Suharjono Suharjono, Yulistiani Yulistiani, Dwi Hari Susilo. ANALYSIS OF NACL-MANNITOL HYDRATION ON RENAL FUNCTION OF HEAD AND NECK CANCER PATIENTS RECEIVING HIGH-DOSE CISPLATIN CHEMOTHERAPY COMBINATIONFolia Medica Indonesiana 2017; 53(1): 64 doi: 10.20473/fmi.v53i1.5492
6
Manal El Hamamsy, Noha Kamal, Naglaa Samir Bazan, Mostafa El Haddad. Evaluation of the effect of acetazolamide versus mannitol on cisplatin-induced nephrotoxicity, a pilot studyInternational Journal of Clinical Pharmacy 2018; 40(6): 1539 doi: 10.1007/s11096-018-0677-x
7
Foroud Shahbazi, Sanambar Sadighi, Simin Dashti-Khavidaki, Farhad Shahi, Mehrzad Mirzania, Alireza Abdollahi, Mohammad-Hossein Ghahremani. Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical TrialPhytotherapy Research 2015; 29(7): 1046 doi: 10.1002/ptr.5345
8
Shigeo Horie, Mototsugu Oya, Masaomi Nangaku, Yoshinari Yasuda, Yasuhiro Komatsu, Motoko Yanagita, Yuko Kitagawa, Hiroyuki Kuwano, Hiroyuki Nishiyama, Chikashi Ishioka, Hiromasa Takaishi, Hideki Shimodaira, Akira Mogi, Yuichi Ando, Koji Matsumoto, Daisuke Kadowaki, Satoru Muto. Guidelines for treatment of renal injury during cancer chemotherapy 2016Clinical and Experimental Nephrology 2018; 22(1): 210 doi: 10.1007/s10157-017-1448-z
9
Takamitsu Inoue, Jun Miyazaki, Daishi Ichioka, Shintaro Narita, Susumu Kageyama, Mikio Sugimoto, Koji Mitsuzuka, Yusuke Shiraishi, Hidefumi Kinoshita, Hironobu Wakeda, Takeshi Nomoto, Eiji Kikuchi, Yoshiyuki Matsui, Keiko Fujie, Tomonori Habuchi, Hiroyuki Nishiyama. A comparison of nephrotoxicity between patients with a solitary-functioning kidney and those with bilateral-functioning kidneys in cisplatin-based chemotherapy for advanced urothelial carcinoma: a Japanese retrospective multi-institutional studyBMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4186-z
10
Wiem Ben Ayed, Azza Ben Said, Adel Hamdi, Amina Mokrani, Yosri Masmoudi, Imen Toukabri, Imen Limayem, Yosra Yahyaoui. Toxicity, risk factors and management of cisplatin-induced toxicity: A prospective studyJournal of Oncology Pharmacy Practice 2020; 26(7): 1621 doi: 10.1177/1078155219901305
11
Kazumi Komaki, Tetsuro Kusaba, Mai Tanaka, Hiroshi Kado, Yayoi Shiotsu, Masahiro Matsui, Atsushi Shiozaki, Hiroshi Nakano, Takeshi Ishikawa, Hitoshi Fujiwara, Hideyuki Konishi, Yoshito Itoh, Satoaki Matoba, Keiichi Tamagaki. Lower blood pressure and risk of cisplatin nephrotoxicity: a retrospective cohort studyBMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3135-6
12
Yenny Prasaja, Noorwati Sutandyo, Retnosari Andrajati. Incidence of Cisplatin-Induced Nephrotoxicity and Associated Factors among Cancer Patients in IndonesiaAsian Pacific Journal of Cancer Prevention 2015; 16(3): 1117 doi: 10.7314/APJCP.2015.16.3.1117
13
Zulfan Zazuli, Renate Kos, Joris D. Veltman, Wilma Uyterlinde, Cristina Longo, Paul Baas, Rosalinde Masereeuw, Susanne J. H. Vijverberg, Anke-Hilse Maitland-van der Zee. Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer PatientsFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00975